US trials for Zandu drug
Zandu Pharmaceutical Works, a Rs 116 crore company, has received the US Food and Drug Administration's approval for conducting investigative clinical trials in American hospitals for a new drug to
Zandu Pharmaceutical Works, a Rs 116 crore company, has received the US Food and Drug Administration's approval for conducting investigative clinical trials in American hospitals for a new drug to